Scenarios that move VTRS
Viatris Inc. - Common Stock
Scenarios that move VTRS: 12 analyses, 7 positive, 5 negative.
- · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +41 · confidence medium · horizon weeks
- · Viatris to acquire Pacira for $1.65B in pain portfolio deal — ▲ · impact +55 · confidence high · horizon quarters
- · HALO wins court order blocking Merck's European Keytruda SC — ▲ · impact +12 · confidence low · horizon quarters
- · Pacira BioSciences shares skyrocket in today's trading — ▲ · impact +58 · confidence low · horizon quarters
- · ◇ What if… Plague outbreak in Russia continues and spreads further — ▲ · impact +40 · confidence low · horizon weeks
- · Liquidia stock plunges 57% after UTHR patent setback — ▼ · impact -7 · confidence low · horizon quarters
- · United Therapeutics stock rises 12.6% in trading — ▼ · impact -10 · confidence low · horizon quarters
- · Novo Nordisk's Ozempic outperforms Lilly's Mounjaro on cardiovascular risk — ▲ · impact +22 · confidence low · horizon quarters
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▼ · impact -28 · confidence medium · horizon quarters
- · Zymeworks updates 2026 guidance after Theravance acquisition — ▲ · impact +18 · confidence low · horizon quarters
- · Xenon files epilepsy NDA as depression study setback weighs — ▼ · impact -10 · confidence low · horizon quarters
- · Definium reports second Phase III success in anxiety program — ▼ · impact -15 · confidence high · horizon quarters